Research output: Contribution to journal › Article › peer-review
167Scopus
citations
Fingerprint
Dive into the research topics of 'Rasagiline mesylate, a new MAO-B inhibitor for the treatment of Parkinson's disease: A double-blind study as adjunctive therapy to levodopa'. Together they form a unique fingerprint.